CMG
47
-3
EMR
60
4
HRL
45
3
CNX
55
2
EQIX
47
2
ADBE
38
-6
VIX
52
-6
EFX
61
3
GIS
60
3
KEY
40
3
EXPE
69
5
EA
65
5
DNB
60
2
DRI
66
2
BEN
36
2
BDX
55
3
ADSK
48
5
AVGO
35
-17
C
53
3
DE
62
2
CMG
47
-3
EMR
60
4
HRL
45
3
CNX
55
2
EQIX
47
2
ADBE
38
-6
VIX
52
-6
EFX
61
3
GIS
60
3
KEY
40
3
EXPE
69
5
EA
65
5
DNB
60
2
DRI
66
2
BEN
36
2
BDX
55
3
ADSK
48
5
AVGO
35
-17
C
53
3
DE
62
2
Financhill
Back

The Vita Coco 10K Form

Buy
59

COCO
The Vita Coco

Last Price:
$35.25
Seasonality Move:
36.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COCO News And Ratings

See the #1 stock for the next 7 days that we like better than COCO

COCO Financial Statistics

Sales & Book Value

Annual Sales: $516M
Cash Flow: $6.8M
Price / Cash Flow: 49.86
Annual Sales: $4.54
Price / Book: 7.76

Profitability

EPS (TTM): 0.94000
Net Income (TTM): $56M
Gross Margin: $198.8M
Return on Equity: 24.22%
Return on Assets: 17.34%

The Vita Coco Earnings Forecast

Key The Vita Coco Financial Ratios

  • The Gross Profit Margin over the past 16 years for COCO is 38.52%.
  • The Selling, General & Administrative Expenses for COCO have been equal to 24.22% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of COCO is 10.84% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

The Vita Coco Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Beverages
Sector: Consumer Staples
Current Symbol: COCO
CUSIP: 218868
Website: vitacoco.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.31
Quick Ratio: 2.38

Price-to-Earnings

Trailing P/E Ratio: 37.51
Forward P/E Ratio: 24.37

COCO Technical Analysis vs Fundamental Analysis

Buy
59
The Vita Coco (COCO) is a Buy

Is The Vita Coco a Buy or a Sell?

  • The Vita Coco stock is rated a Buy
    The current The Vita Coco [COCO] share price is $35.26. The Score for COCO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.